India’s equity markets are expected to receive $1.4 billion to $1.6 billion in inflows as 14 firms join FTSE's All-World ...

AquaSculpt is quickly becoming one of the most talked-about weight loss supplements in 2025, and for a good reason. Unlike traditional fat burners that rely on stimulants, harsh chemicals, or extreme ...

Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management.

Laura Gaylord, DVM, DACVIM (Nutrition) shares the role of diet trials in chronic enteropathy patients during her lecture at ...

Many employers are facing challenges in incorporating high-cost GLP-1 medications, such as Mounjaro, Ozempic, Rybelsus, Trulicity, and Wegovy, ...

Lunch plays a crucial role in fueling your afternoon energy, stabilizing blood sugar, and supporting overall health. While ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

The demand for glucagon-like peptide 1 (GLP-1s) receptor agonists for overweight/obesity has created a clinical conundrum for ...

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...

Scientists at Ohio University have identified a protein that could help fight obesity by improving metabolism and preventing ...

Colorectal cancer rates are rising in younger adults. Learn prevention strategies from screening to lifestyle changes that significantly reduce your risk factor ...

Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...